IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.400
+0.110 (4.80%)
At close: Aug 14, 2025, 4:00 PM
2.400
0.00 (0.00%)
After-hours: Aug 14, 2025, 6:40 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $10.90 million as of August 14, 2025. Its market cap has decreased by -70.46% in one year.
Market Cap
10.90M
Enterprise Value
287.95K
1-Year Change
-70.46%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $10.90M, a decrease of -94.19%. That is a compound annual growth rate of -50.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 10.40M | -44.24% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |